Skip to content

Clinical trials

Phase 2/3 Breast Neoplasms trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 2/3 Status: Unknown status Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20101
20127
20141
20151
20161
20175
20185
20191
20202
20213
20225

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status33

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Tianjin Medical University4
Mansoura University3
Zhiyong Yu3
Assiut University2
Hebei Medical University Fourth Hospital2
Peking Union Medical College Hospital2
Tanta University2
Alexandria University1
Beni-Suef University1
Centro Hospitalar Lisboa Ocidental1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms33
Breast Diseases2
Neoplasm Metastasis2
Brain Neoplasms1
Carcinoma, Non-Small-Cell Lung1
Cardiotoxicity1
Cognitive Dysfunction1
Diarrhea1
Pain1
Peripheral Nervous System Diseases1

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.